2005
Company Will Promptly and Fully Respond to FDA Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) announced today that it has received a warning letter from the U.S. Food and Drug Administration...
SPIRIT III U.S. Randomized Enrollment Passes Halfway Mark Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company has begun enrollment in the Japan arm of its SPIRIT...
Advanced Lead is Designed to Enable Physicians to Overcome Challenging Left Ventricular Anatomy Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT) today announced Conformité...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that its Board of Directors has made the requisite determination under Guidant's merger agreement with Johnson & Johnson to...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) acknowledges receipt of a letter dated today, , outlining a proposed transaction with Boston Scientific. Guidant's Board of Directors will...
Ronald W. Dollens Retires after 11 Years as CEO; Special Shareholder Meeting Anticipated in January Indianapolis, Ind. - In a joint press release issued earlier today, Guidant Corporation (NYSE:...
Results Demonstrate Sustained Benefit of the XIENCE V Everolimus Eluting Coronary Stent System Indianapolis, Ind., and Dallas, Texas - Guidant Corporation (NYSE: GDT) today announced 12-month...
Data from Study Will Support Launch of XIENCE V Coronary Stent System Outside the United States Indianapolis, Ind. and Brussels - Guidant Corporation (NYSE: GDT) today announced that the company...
Cardiac Rhythm Management Report Delivers Unprecedented Level of Information Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) announced today the easy availability of even more detailed...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company''s board of directors declared a fourth quarter dividend of $0.10 per share on outstanding common stock. This...
Design for Reliability Team Reflects Company Commitment to Quality Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced the establishment of an outside team of experts to point the...
Company Reports Third Quarter Sales of $795 Million Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, announced that it is...
Indianapolis, Ind. - We at Guidant Corporation (NYSE:GDT) take seriously the issues raised in the October 20 article in The New York Times titled: Behind Heart Implants, a History of Defects and a...
Transcript Now Available on Company Website Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) announced today that the Company has published its responses to the Form 483 observations issued by...
Innovative Wireless System Conveniently Monitors Device Status From the Comfort of the Patient''s Home Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced U.S....
Guidant-Supported Grant Honors Late Chief Medical Officer Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that Dr. Giuseppe De Luca of Hospital De Weezenlanden, Zwolle, The...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it has received administrative subpoenas from the United States Department of Justice U. S. Attorney's offices in Boston...
Large-Scale Pivotal Trial to Evaluate Safety and Efficacy of Next-Generation XIENCE V Coronary Stent System Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company...
Study Suggests Therapy Can Be Performed Safely by Broad Group of Physicians Indianapolis, Ind. and Washington, D.C. - Guidant Corporation (NYSE: GDT) today announced preliminary results of its...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the Federal Trade Commission (FTC) has agreed to...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today responded to statements by Johnson & Johnson on its pending acquisition...
MULTI-LINK VISION® RX Coronary Stent System Provides Thin Struts, Superb Deliverability and Excellent Clinical Results Indianapolis, Ind. and Tokyo - Guidant Corporation (NYSE: GDT) today...
High Energy System Addresses Growing Physician Demand for More Defibrillation Energy Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT) today announced U.S. Food and Drug...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said today that it is informing physicians about two separate failure modes, each occurring at a low rate, being monitored within the...
Indianapolis, Ind. - Guidant announced today that the U.S. Food and Drug Administration (FDA) has completed its inspection of Guidant's Cardiac Rhythm Management facilities in St. Paul, Minnesota,...
Successful Inspection Brings Company One Step Closer to European Approval; Drug Eluting Stent Milestone Results in Payment to Novartis in Third Quarter Indianapolis, Ind. - Guidant Corporation...
Innovative Technology Directed Toward Compliance in Heart Failure Patients at Risk of Sudden Cardiac Death Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced...
European Commission Ruling Necessitates Organizational and Staffing Adjustments Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that as a result of the European Commission...
Approval Sufficient for Completion of Pivotal Trial Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company has received approval from the U.S. Food and Drug...
Guidant Announces Full Availability of Cardiac Rhythm Management Product Line Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced U.S. Food and Drug...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company''s board of directors declared a third quarter dividend of $0.10 per share on outstanding common stock. This...
Company Expects to Resume Implants and Distribution by Mid-week Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said today that it received U.S. Food and Drug Administration (FDA) approval to...
Robert J. Myerburg, M.D., Internationally Recognized Leader in Electrophysiology Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that Dr. Robert J. Myerburg, Professor of...
CE Mark Clears Way for Guidant to Reenter Market Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said today that it received Conformité Européenne (CE) Mark approval to launch its CONTAK...
Guidant Updates Corrective Actions Regarding Its VENTAK PRIZM AVT, VITALITY AVT, and CONTAK RENEWAL AVT Implantable Cardiac Defibrillators Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said...
Worldwide implantable defibrillator revenue of $470 million, up 3 percent Worldwide coronary stent revenue of $118 million, down 2 percent Worldwide revenue from emerging businesses of $97...
District Court for Delaware Upholds Validity of Mirowski Patent Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it won a key decision in a heart failure device patent...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said today it is voluntarily advising physicians about important safety information regarding certain devices. Guidant apprised FDA of this...
Data From Study Will Support Launch of XIENCE V Coronary Stent System Outside the United States Indianapolis, Ind. and Brussels - Guidant Corporation (NYSE: GDT) today announced that the company...
Study Designed to Evaluate the Safety and Efficacy of Surgical Microwave Ablation Technology to Treat Common Heart Arrhythmia Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation...
Guidant Reiterates its Previous Physician and Patient Recommendations Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said today that FDA has classified its June 17, 2005 and June 24, 2005...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said today it is voluntarily advising physicians about important safety information regarding certain devices. Guidant apprised FDA of this...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced its intention to establish an independent panel of experts to recommend guidelines for when to disseminate information to...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said today it is voluntarily advising physicians about important safety information regarding certain devices. Guidant has apprised FDA of...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) initiated a communication to physicians regarding the clinical performance of its VENTAK PRIZM® 2 DR Model 1861 implantable defibrillator....
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it has received Investigational Device Exemption (IDE) conditional approval from the U.S. Food and Drug Administration...
Guidant Shareholders Overwhelmingly Approve Acquisition Agreement with Johnson & Johnson
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) announced that at a special meeting of shareholders held today in Indianapolis, Guidant shareholders overwhelmingly approved the agreement...
New Brunswick, N.J., and Indianapolis, Ind. - Johnson & Johnson and Guidant Corporation today announced that they have been notified, as anticipated, that the European Commission has decided to...
Company Completes Several Merger-Related Milestones During Quarter Sales of products other than worldwide coronary stents were $838 million, up 10 percent Worldwide implantable defibrillator...
Shareholders of Record on March 21, 2005 Eligible to Vote Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that its shareholders will vote on Wednesday, April 27, 2005, on a...
Grant Will Support Research and Training to Understand and Treat America's Number One Killer of Women Orlando, Fla. - The Guidant Foundation and the American College of Cardiology Foundation...
New Brunswick, N.J. and Indianapolis, Ind. - Johnson & Johnson (NYSE: JNJ) and Guidant Corporation (NYSE: GDT) today announced that they received an anticipated Request for Additional Information...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company''s board of directors declared a first quarter dividend of $0.10 per share on outstanding common stock. The...
Free Medical Screenings Offered to the Public in Partnership with Red Dress Collection 2005 Fashion Show New York - According to the American Heart Association, 37 million American women have...
Company to repatriate $1.5 billion and record $104 million additional tax expense related to American Jobs Creation Act of 2004 Sales of products other than worldwide coronary stents grew $426...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) will announce financial results for the fourth quarter and full-year 2004 on January 27, 2005. A press release will be issued before the...
Company Named To Prestigious Ranking For Fifth Time Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it has been selected as one of FORTUNE's 100 Best Companies to Work...